Unimark Remedies Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN U23200MH1993PLC075373 Incorporated 01 December 1993 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Public Limited Company pharma
Data last updated
Revenue · Latest
-
Latest filing
EBITDA · Latest
Locked
In full report
Net profit · Latest
Locked
In full report
Authorised capital
₹57.01 Cr
Registered with MCA
Paid-up capital
₹10 Cr
Issued & subscribed
Open charges
₹1,105.65 Cr
Satisfied ₹344.73 Cr
Company age
33 yrs
Est. 1993
Employees · EPFO
4
Latest available

About Unimark Remedies Limited

Data last updated: 23 December 2025

Unimark Remedies Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 01 December 1993, the company has been in operation for over 33 years.

Registered with ROC Mumbai under CIN U23200MH1993PTC075373.

Capital: an authorised share capital of ₹57.01 Cr and a paid-up capital of ₹10 Cr. Formerly known as Unimark Remedies Private Limited. It is led by directors including Sonalika Sushant Shrivastav and Jitesh Khokhani Rameshchandra.

Last AGM: 29 December 2018. Financial statements filed for year ended 31 March 2018. Office: Mumbai, Maharashtra.

The company has a workforce of approximately 4 employees as per the latest available data.

The company is associated with 1 brand - Unimark Remedies. As per MCA filings, the company has open charges of ₹1,105.65 Cr and satisfied charges of ₹344.73 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website unimarkremedies.com.

Company Details of Unimark Remedies Limited
CIN U23200MH1993PLC075373
Registration Number 075373
Incorporation Date 01 December 1993
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 December 2018
Date of Balance Sheet 31 March 2018
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
  • Registered Address
    Plot – 83C Ground Floor Motor Cycle Building Laxminarsingh, Papan Marg Off. Dr. E Moses Road Gandhi Nagar Worli, Mumbai, Maharashtra, India – 400018
  • Industry
    Pharma, API Manufacturers
Company report
Unimark Remedies Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Unimark Remedies Limited report

Financials, compliance, directors, charges, ownership and filings for Unimark Remedies Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Unimark Remedies Limited

Unimark Remedies Limited has one previous CIN (Corporate Identification Number): U23200MH1993PTC075373. The current CIN is U23200MH1993PLC075373, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U23200MH1993PLC075373 Current
U23200MH1993PTC075373 Previous

Associated Brands with Unimark Remedies Limited

Unimark Remedies Limited operates one associated brand: Unimark remedies. These brands represent Unimark Remedies Limited's diversified market presence and brand portfolio.

Brand Description Website
Traditional vertically integrated pharmaceutical company having presence in various business segments unimarkremedies.com

Competitors & Alternatives of Unimark Remedies Limited

Brands and companies operating in the same space as Unimark Remedies Limited include Concord Biotech, Almac Group, Indoco Remedies and 6 more.

Competitor Description Location Founded
Concord Biotech Concord Biotech APIs and enzymes are manufactured through fermentation by the CDMO. Ahmedabad, India, India 2000
Almac Group Almac Group Integrated CDMO services for biopharma R&D and manufacturing are offered. Craigavon, United Kingdom, United Kingdom 2001
Indoco Remedies Indoco Remedies APIs manufacturing and formulation services are provided in therapeutic segments. Mumbai, India, India 1947
Pharmaceutics International Pharmaceutics International Pharmaceutical dosage forms are manufactured by this CDMO. Hunt Valley, United States, United States 1994
Aurobindo Pharma Aurobindo Pharma Generic biocatalytic solutions are provided for pharmaceutical applications. Hyderabad, India, India 1986
Seqens Seqens Contract manufacturing services for small molecules and peptides are provided. Ecully, France, France 2003
Asymchem Asymchem APIs and peptides are developed and manufactured by Asymchem. Morrisville, United States, United States 1995
Aptuit Aptuit Contract research and development services for small molecules are offered. Greenwich, United States, United States 2004
Continuus Pharma Continuus Pharma MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development Woburn, United States, United States 2012

Business Activity of Unimark Remedies Limited

Unimark Remedies Limited operates primarily in the manufacturing sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
Locked Manufacturing Locked Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Detailed business activity records for Unimark Remedies Limited

Activity codes and turnover contribution percentages require an active report plan.

  • Activity group codes
  • Detailed activity codes
  • Turnover contribution

Verified entity values are shown only after access is granted.

Board of Directors and KMP of Unimark Remedies Limited

Unimark Remedies Limited currently reports 3 directors and 1 key managerial person. 29 former directors have served the organization.

Current Directors and KMP
Name Designation Appointment Date Tenure Status
Sonalika Sushant Shrivastav Additional Director 06 Sep 2024 1 Years 10 Months Current
Jitesh Khokhani Rameshchandra Director 26 May 2023 3 Years 2 Months Current
Ketan Bhupendrabhai Parikh Additional Director 27 May 2023 3 Years 2 Months Current
Kamlesh Rameshchandra Khokhani Cfo 06 Sep 2024 1 Years 10 Months Current

Financials of Unimark Remedies Limited FY 2018 filings available

Premium access

Ten-year financial statements for Unimark Remedies Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Charges & Borrowings of Unimark Remedies Limited

Open charges
₹1,105.65 Cr
Satisfied charges
₹344.73 Cr
Breakdown by lending institutions
Idbi Trusteeship Services Limited₹913.75 Cr
Others₹142.83 Cr
Citi Bank N.A.₹41.00 Cr
Canara Bank₹6.95 Cr
Sidbi₹1.00 Cr
Others₹0.11 Cr
Latest charge details
DateLenderAmountStatus
02 Sep 2025 Others ₹35 Cr Open
30 Jul 2024 Others ₹50 Cr Open
03 Jun 2014 Idbi Trusteeship Services Limited ₹913.75 Cr Open
06 Mar 2013 Others ₹1.8 Cr Open
06 Mar 2013 Others ₹49.04 Lakh Open

Total charge records: 59 View all charges

Employees and EPFO Compliance at Unimark Remedies Limited

View historical data on people associated with Unimark Remedies Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Unimark Remedies Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Unimark Remedies Limited

Premium access

GST registrations and filing compliance for Unimark Remedies Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Unimark Remedies Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Unimark Remedies Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Unimark Remedies Limited

Premium access

MSME payment history for Unimark Remedies Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Unimark Remedies Limited

Premium access

Corporate group structure for Unimark Remedies Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Unimark Remedies Limited

Premium access

MCA filings and documents for Unimark Remedies Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Unimark Remedies Limited

Charges
02 Sep 2025
A charge with Others amounted to Rs. 35.00 Cr with Charge ID 101158384 was registered on 02 Sep 2025.
Directors
16 Aug 2025
Kamlesh Rameshchandra Khokhani was appointed as a Cfo on 16 Aug 2025 & has been associated with this company since 11 months 12 days.
Charges
06 Aug 2025
A charge registered on 22 Sep 2009 via Charge ID 10176412 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 06 Aug 2025.
Charges
06 Aug 2025
A charge registered on 27 May 2008 via Charge ID 10141701 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 06 Aug 2025.
Charges
06 Aug 2025
A charge registered on 02 Apr 2007 via Charge ID 10050722 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 06 Aug 2025.
Charges
06 Aug 2025
A charge registered on 02 Apr 2007 via Charge ID 10049603 with The Hongkong And Shanghai Banking Corporation Limited was fully satisfied on 06 Aug 2025.

Frequently Asked Questions about Unimark Remedies Limited

Unimark Remedies Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 01 December 1993 (33+ years old) and is registered under CIN U23200MH1993PLC075373. The company has 4 employees.

The current directors and KMP of Unimark Remedies Limited are:

The primary industry of Unimark Remedies Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.

Unimark Remedies Limited can be reached at the registered office: Plot – 83C Ground Floor Motor Cycle Building Laxminarsingh, Papan Marg Off. Dr. E Moses Road Gandhi Nagar Worli, Mumbai, Maharashtra, India – 400018, or through the website unimarkremedies.com.

The authorised capital is ₹57.01 Cr, and the paid-up capital is ₹10 Cr.

The company has its registered office at Plot – 83C Ground Floor Motor Cycle Building Laxminarsingh, Papan Marg Off. Dr. E Moses Road Gandhi Nagar Worli, Mumbai, Maharashtra, India – 400018.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available